Paclitaxel

Overview

Paclitaxel is a chemotherapy drug used to treat various types of cancer, including ovarian, breast, and non-small cell lung cancer. It works by interfering with the normal function of microtubules during cell division.

API suppliers (29)

Suppliers of Paclitaxel evidenced by a US FDA Type II Drug Master File or an EU Certificate of Suitability (CEP). Sources: FDA DMF list, EDQM certification database.

• SCINOPHARM TAIWAN LTDTaiwan2 active DMF
• SERIPHARM SASFrance1 active DMF
• TAPI NL BVNetherlands1 active DMF
• Intas Pharmaceuticals Ltd.India1 active DMF GMP on record
• SAMYANG HOLDINGS CORPSouth Korea1 active DMF GMP on record
• WUHAN CALMLAND PHARMACEUTICALS CO LTDChina1 active DMF GMP on record
• Hetero Labs LimitedIndia1 active DMF GMP on record
• MSN Laboratories Private LimitedIndia1 active DMF GMP on record
• YUNG SHIN PHARMACEUTICAL INDUSTRIAL CO LTD1 active DMF
• APITORIA PHARMA PRIVATE LTDIndia1 active DMF GMP on record
• LD PHARMACEUTICAL
• MAC CHEM PRODUCTS INDIA PVT LTD GMP on record
• TAIHUA NATURAL PLANT PHARMACEUTICAL CO LTD
• SHANGHAI JINSHAN BIOTECH CO LTD
• BEIJING YI HE BIOTECH CO LTD
• SAI PHYTOCEUTICALS PVT LTD
• JIANGSU YEW PHARMACEUTICAL CO LTD
• ARCH PHARMALABS LTDIndia
• POLYMED THERAPEUTICS INC
• BIOXEL PHARMA INC
• HAUSER CHEMICAL RESEARCH INC
• GREEN SPRINGS BIOCHEMISTRY
• PHYTOGEN LIFE SCIENCES INC
• CHONGQING UNIT MODERN TECHNOLOGY CO LTD
• HUIANG BIO CHEMICAL PRODUCT MANUFACTURE COMPANY LTD

Showing 25 of 29 suppliers — see the full list in the app.

EU CEP holders (1)

Companies holding a valid EU Certificate of Suitability (CEP) for Paclitaxel, from the EDQM certification database. A CEP holder is a documented EU-market source of the substance — not necessarily the manufacturer — and these are not yet profiled in our directory.

Patent & exclusivity (US)

Per the FDA Orange Book (16 approved US products), the latest listed US patent on Paclitaxel expires 12 Jul 2034. Generic API sourcing typically opens up once these lapse.

Therapeutic areas